Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hong

Showing results (1341-1350 of 1,404) with videos related to

Pageof 141
Sort By:
JCI Insight|September 22, 2017
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunityPearl Bakhru, Meng-Lei Zhu, Hsing-Hui Wang, et al.
Journal of Korean Medical Science|January 17, 2014
A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarctionJun-Won Lee, Seung-Hwan Lee, Young-Jin Youn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
British Journal of Cancer|May 24, 2012
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisY S Lee, I Choi, Y Ning, et al.
Annals of Internal Medicine|July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymomaD M Shin, G L Walsh, R Komaki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Cancer|November 6, 2003
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou, Lawrence E Ginsberg, Adam S Garden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesotheliomaCharles Lu, Roman Perez-Soler, Bilal Piperdi, et al.
Pageof 141

Showing results (1341-1350 of 1,404) with videos related to

Sort By:
Pageof 141
JCI Insight|September 22, 2017
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunityPearl Bakhru, Meng-Lei Zhu, Hsing-Hui Wang, et al.
Journal of Korean Medical Science|January 17, 2014
A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarctionJun-Won Lee, Seung-Hwan Lee, Young-Jin Youn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
British Journal of Cancer|May 24, 2012
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisY S Lee, I Choi, Y Ning, et al.
Annals of Internal Medicine|July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymomaD M Shin, G L Walsh, R Komaki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Cancer|November 6, 2003
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou, Lawrence E Ginsberg, Adam S Garden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesotheliomaCharles Lu, Roman Perez-Soler, Bilal Piperdi, et al.
Pageof 141